Aileron Therapeutics, Inc. (ALRN)

NASDAQ: ALRN · IEX Real-Time Price · USD
0.440
0.000 (0.02%)
At close: May 20, 2022 3:59 PM
0.430
-0.010 (-2.273%)
After-hours:May 20, 2022 4:58 PM EDT

Income Statement (Trailing)

Millions USD. Fiscal year is Jan - Dec.
Period Ended2022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
Selling, General & Admin
9.459.69.619.449.29.339.710.811.9612.2912.6812.4113.6813.4513.1612.5910.048.777.46.428.097.89---5.06
Research & Development
18.5917.0114.3712.7811.4111.1713.9515.7417.5617.6616.9116.7617.7818.4518.818.316.1414.2413.0211.810.7310.28---7.83
Other Operating Expenses
000000-0.07-0.07-0.0700000000000000000
Operating Expenses
28.0426.6123.9822.2220.6120.523.5926.4729.4529.9629.5929.1731.4531.931.9630.8926.1823.0120.4218.2218.8218.17---12.89
Operating Income
-28.04-26.61-23.98-22.22-20.61-20.5-23.59-26.47-29.45-29.96-29.59-29.17-31.45-31.9-31.96-30.89-26.18-23.01-20.42-18.22-18.82-18.17----12.89
Other Expense / Income
-0.43-0.440.380.460.780.66-0.19-0.35-0.55-0.59-0.42-0.32-0.28-0.36-0.58-0.69-0.55-0.4-0.23-0.08-0.06-0.05000-0.01
Pretax Income
-27.61-26.16-24.36-22.68-21.38-21.16-23.4-26.12-28.9-29.37-29.17-28.85-31.17-31.55-31.38-30.2-25.64-22.6-20.18-18.14-18.76-18.12000-12.88
Net Income
-27.61-26.16-24.36-22.68-21.38-21.16-23.4-26.12-28.9-29.37-29.17-28.85-31.17-31.55-31.38-30.2-25.64-22.6-20.18-18.14-18.76-18.12----12.88
Preferred Dividends
00000000000000000.020.040.060.080.080.08---0.07
Net Income Common
-27.61-26.16-24.36-22.68-21.38-21.16-23.4-26.12-28.9-29.37-29.17-28.85-31.17-31.55-31.38-30.2-25.66-22.65-20.24-18.22-18.83-18.2----12.95
Shares Outstanding (Basic)
91899190833539312825282815151515157140000000
Shares Outstanding (Diluted)
9189919083353931282528281515151515714000---0
Shares Change
8.74%154.70%130.28%189.73%199.83%42.11%41.39%13.42%87.70%66.48%88.71%86.78%0.57%98.01%5.72%3171.34%3304.51%1632.21%---7.23%----
EPS (Basic)
-0.29-0.29-0.33-0.39-0.47-0.61-0.76-0.91-1.03-1.20-1.51-1.73-2.11-2.14-1.54-1.49-11.83-3.04-32.32-41.71-43.68-42.35----32.31
EPS (Diluted)
-0.29-0.29-0.33-0.39-0.47-0.61-0.76-0.91-1.03-1.20-1.51-1.73-2.11-2.14-1.54-1.49-11.83-3.04-32.32-41.71-43.68-42.35----32.31
Free Cash Flow Per Share
-0.28-0.27-0.24-0.22-0.26-0.58-0.56-0.77-0.89-1.08-1.04-1.13-2.23-2.19-2.01-1.75-1.47-2.78-1.36-39.21-39.88-34.94----29.46
EBITDA
-27.45-26.04-24.27-22.61-21.29-20.99-23.17-25.89-28.71-29.21-29.04-28.66-30.97-31.33-31.17-30.04-25.48-22.48-20.05-18-18.57-17.89----12.55
EBIT
-27.61-26.16-24.36-22.68-21.38-21.16-23.4-26.12-28.9-29.37-29.17-28.85-31.17-31.55-31.38-30.2-25.64-22.6-20.18-18.14-18.76-18.12----12.88
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).